Skip to main content
INMB logo

INMB

INmune Bio, Inc.

$0.83

7.17%

Trade Ideas Performance

Latest Closed Trade Idea

$0.83

7.17%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

6

Social

27

About

Events of INmune Bio, Inc. (INMB)

Over the past six months, INmune Bio, Inc.'s stock has been impacted by several events. In August 2026, the company released Q2 2026 earnings, reporting a narrower net loss and a strong cash position, and submitted Orphan Drug Designation and pre-MAA Scientific Advice packages for Ebstrocel to the EMA. In September 2026, new board appointments were announced, enhancing commercial and strategic leadership. By October 2026, INmune Bio submitted its final pre-MAA package for Ebstrocel to the UK MHRA, with a complete MAA planned for early February 2027 and potential UK approval by mid-2027. Q3 2026 financial results, announced in November 2026, showed a narrower net loss and reduced expenses, with cash sufficient to fund operations through Q3 2027. The company also raised $4.5 million in gross proceeds through a financing round in October 2026. Despite this, the latest 10-Q included a warning about insufficient liquidity to sustain operations for one year, raising substantial doubt about the company's ability to continue as a going concern. Analyst ratings varied, with Wall Street Zen upgrading the stock to 'hold' while Praetorian PR LLC significantly lowered its stake. In the last year, INMB shares experienced a 52-week high of $2.60 and a 52-week low of $1.03.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)